+91-8668442535

Endobronchial Ultrasound (EBUS) Biopsy Devices Market By Product (EBUS-TBNA Systems & Needles, Bronchoscopes & Probes, Ultrasound Processors, Biopsy Forceps & Needles, Cytology Brushes & Spray Catheters, Others), By Indication (Lung Cancer Diagnosis, Infection Diagnosis, Others), By End-User (Hospitals, Ambulatory Surgery Centers (ASCs), Specialty Clinics, Others) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

Endobronchial Ultrasound (EBUS) Biopsy Devices Market to Exhibit Healthy Growth during the Forecast Period from 2018 to 2026

The global endobronchial ultrasound biopsy devices market accounted for a value of US$ 492.0 million in 2017 and is expected to attain US$ 753.6 million by 2026. Worldwide growing elderly population coupled with the increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), lung cancer, pleural mesothelioma, and tuberculosis (TB) are anticipated to foster market growth over the forecast period. In addition, extensive technological developments in endobronchial ultrasound devices and rising patient preference for minimally invasive surgeries (MISs) are expected to exhibit significant sales forecasts in the near future. The World Health Organization (WHO) reported that the global elderly population will surge from 841.0 million in 2013 to 962.3 million in 2017 and more than 2 billion by 2050. The older population is more susceptible to developing respiratory diseases. As per the data published by the World Cancer Research Fund (WCRF) International, currently, lung cancer causes 1.69 million deaths. According to the American Lung Association, presently, around 415,000 Americans are diagnosed with lung cancer. In 2016, about 224,390 new cases of lung cancer were diagnosed in America. In contrast, the high cost of EBUS devices and the scarcity of reimbursement policies in a few developing countries will limit the adoption of endobronchial ultrasound devices during the forecast period.

Market Synopsis

"The EBUS-TBNA Systems and Needles Segment led the market in 2017."

The endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) systems and needles segment would continue its dominance during the forecast period owing to its rising use in staging lung cancer in malignant and benign tumors, sampling enlarged mediastinal lymph nodes, and diagnosing sarcoidosis or tuberculosis. On the other hand, the Others segment registered the highest market growth from 2018 to 2026, which is attributed to its disposable nature and repetitive purchase of cleaning brushes, bite blocks, injection needles, and EBUS accessories.

"Based on Indication, Lung Cancer Diagnosis Segment forecast to Command the Market between 2018 and 2026."

Among indications, the lung cancer diagnosis segment dominated the market due to the extensive use of EBUS devices in diagnosing and staging lung cancer, such as non-small cell lung cancer (NSCLC). EBUS is superior to other diagnostic modalities such as computed tomography (CT)-guided biopsy, positron emission tomography (PET) imaging, and pleural effusion cytology for the detection and staging of lung cancer.

"Hospitals Segment Contributes Maximum to the Overall Growth of Endobronchial Ultrasound Biopsy Devices Market"

A gradual rise in the number of government & private hospitals in emerging countries such as China & India, coupled with an increase in the number of EBUS procedures performed in hospitals, is assisting in the dominance of the hospitals segment. In terms of value, the U.S. holds a large chunk of the market; however, a diminishing number of hospitals in recent years is limiting the market growth. Ambulatory surgery centers (ASCs) are likely to witness the highest market growth during the next nine years as ASCs can enhance quality and customer service while concurrently reducing costs, and same-day discharge after the treatment has resulted in a gradual rise in the number of EBUS procedures. The ambulatory surgery centers industry established itself to be ahead of the curve in identifying promising avenues for improving the healthcare delivery that is fostering this profitable market growth.

"North America Holds Dominant Position Attributed to Higher Demand for Advanced Diagnostic Techniques in Gastroenterology, Pulmonology, and Oncology"

North America led the market in 2017 due to the presence of major market participants, the rising prevalence of lung cancer, and the availability of advanced diagnostic techniques in the U.S. and Canada. Asia Pacific is expected to exhibit lucrative sales forecasts during the forecast period attributed to the rising prevalence of lung cancer & COPD, increasing medical tourism, and low manufacturing costs of medical devices in India and China. Additionally, the presence of medical imaging giants such as Olympus Corporation and FUJIFILM Corporation in Japan are significantly contributing to the regional market growth.

The Presence of Multinational Market Participants Makes Market Penetration Challenging for New Entrants

Major players in this space are Medtronic plc; Boston Scientific Corporation, Olympus Corporation; FUJIFILM Corporation; Cook Medical; CONMED Corporation; Medi-Globe GmbH; Veran Medical Technologies; and PENTAX Medical. These companies are adopting organic & inorganic growth strategies, including new product launches, mergers & acquisitions, partnerships, and collaborations in order to gain a competitive advantage. Market participants are establishing their position in the market and relishing brand loyalty among customers. New market entrants are facing tough rivalry from established multinational players as they struggle with technological innovations or developments, product reliability, quality issues, and post-sale services.

Historical & Forecast Period

This study report represents an analysis of each segment from 2016 to 2026, considering 2017 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2018 to 2026

Report Scope by Segments

The endobronchial ultrasound biopsy devices market covers the qualitative analysis of current market dynamics & quantitative analysis of the global market. The report entails comprehensive information on the global endobronchial ultrasound biopsy devices market by segmenting the market based on product, indication, end-user, and geography. This report will guide industry investors & associations, medical device vertical players, research & consulting firms, venture capitalists, and healthcare professionals (HCPs) in decision-making and strategizing the market position.

The current report also encompasses qualitative analysis of market variables such as key market drivers, restraints, opportunities, and trends that provide better market information on the entire endobronchial ultrasound biopsy devices market. In addition, the report also encompasses a graphical representation of the competitive landscape based on their market initiatives & strategies, product portfolio, financial information, and key developments. Major market participants profiled in the study report are Medtronic plc; Olympus Corporation; Boston Scientific Corporation; Cook Medical; CONMED Corporation; Medi-Globe GmbH; Veran Medical Technologies; FUJIFILM Corporation; and PENTAX Medical.

Key questions are answered in this report.

  • What are the current market trends and dynamics in the endobronchial ultrasound biopsy devices market, and what are the valuable opportunities for emerging players?
  • Which product contributes to the maximum market share?
  • Which product accounts for the fastest CAGR during the forecast period?
  • Which indication held the major market share in 2017?
  • Which indication would be the fastest segment during the forecast period?
  • Which end-user holds a larger market share and why?
  • What is the impact of high-cost EBUS devices on the market?
  • Are low- and middle-income economies investing in endobronchial ultrasound biopsy devices?
  • What are the market trends and dynamics in emerging markets such as Latin America, the Middle East, and Africa?

Frequently Asked Questions:

The market for Endobronchial Ultrasound (EBUS) Biopsy Devices Market is expected to reach US$ 753.6 million by 2026.

The Endobronchial Ultrasound (EBUS) Biopsy Devices Market is expected to see significant CAGR growth over the coming years,at XX%.

The report is forecasted from 2018 – 2026.

The base year of this report is 2017.

Medtronic plc; Olympus Corporation; Boston Scientific Corporation; Cook Medical; CONMED Corporation; Medi-Globe GmbH; Veran Medical Technologies; FUJIFILM Corporation; and PENTAX Medical. are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Aug 2018
Category:  Medical Devices
Report ID:   59254
Report Format:   PDF
Pages:   120
Rating:    4.5 (70)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support